Skip Navigation

Medical Product Safety

Hospitals reporting adverse drug events (percent)

2020 Baseline (year): 60.7 (2009)
2020 Target: 66.8
Desired Direction: Increase
Populations 2009        
Total 60.7









Footnotes View Footnotes

Data are subject to revision and may have changed since a previous release.

Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.

Data are not available or not collected for populations not shown.

CI: 95% confidence interval.

Non-FDA-approved pain medications on the market (number)

2020 Baseline (year): 575 (2007)
2020 Target: 518
Desired Direction:

Non-FDA-approved pain medications on the market (number)

2020 Baseline (year): 575 (2007)
2020 Target: 518
Desired Direction: Decrease
Populations 2007        
Total 575









Footnotes View Footnotes

Data are subject to revision and may have changed since a previous release.

Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.

Data are not available or not collected for populations not shown.

CI: 95% confidence interval.

Emergency department visits for overdoses from oral anticoagulants (per 10,000 outpatient prescription visits)

2020 Baseline (year): 35.9 (2006-2007)
2020 Target: 32.3
Desired Direction:

Emergency department visits for overdoses from oral anticoagulants (per 10,000 outpatient prescription visits)

2020 Baseline (year): 35.9 (2006-2007)
2020 Target: 32.31
Desired Direction: Decrease
Populations 2006-20072 2008-2009      
Total 35.9
CI 19.8 / 51.9
SE 8.175
36.9
CI 20.2 / 53.6
SE 8.536






Sex









Female 39.4
CI 20.0 / 58.8
SE 9.885
37.3
CI 19.4 / 55.2
SE 9.136






Male 32.5
CI 18.4 / 46.5
SE 7.173
36.4
CI 20.1 / 52.7
SE 8.310






Age group









<18 DSU

DSU







   5-11 DSU

DSU







   12-17 DSU

DSU







   0-4 DSU

DSU







18-44 29.5
CI 11.8 / 47.1
SE 9.003
35.8
CI 12.5 / 59.0
SE 11.854






   18-24 DSU

DSU







   25-44 30.1
CI 11.9 / 48.4
SE 9.311
37.9
CI 13.7 / 62.1
SE 12.349






65 and over 38.0
CI 21.2 / 54.8
SE 8.594
37.9
CI 20.3 / 55.4
SE 8.952






   65-74 31.4
CI 18.2 / 44.6
SE 6.755
35.2
CI 17.7 / 52.7
SE 8.931






   75-84 35.4
CI 18.5 / 52.4
SE 8.648
34.6
CI 17.9 / 51.4
SE 8.549






   85 and over 60.0
CI 28.6 / 91.4
SE 16.020
50.4
CI 26.2 / 74.6
SE 12.349






45-64 30.3
CI 20.0 / 40.6
SE 5.254
33.3
CI 20.3 / 46.2
SE 6.605






   55-64 28.6
CI 14.2 / 43.0
SE 7.331
33.2
CI 17.4 / 48.9
SE 8.039






   45-54 34.0
CI 12.9 / 55.0
SE 10.740
33.5
CI 15.3 / 51.7
SE 9.277






Footnotes View Footnotes

1Target has been revised. See Tech Specs for details.

2Baseline has been revised. See Tech Specs for details.

DSU: Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

Data are subject to revision and may have changed since a previous release.

Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.

Data are not available or not collected for populations not shown.

CI: 95% confidence interval.

Emergency department visits for overdoses from injectable antidiabetic (per 10,000 outpatient prescription visits)

2020 Baseline (year): 43.4 (2006-2007)
2020 Target: 39.11
Desired Direction: Decrease
Populations 2006-20072 2008-2009      
Total 43.4
CI 24.1 / 62.8
SE 9.881
34.2
CI 20.2 / 48.2
SE 7.129






Sex









Female 37.8
CI 21.0 / 54.7
SE 8.613
31.2
CI 18.1 / 44.3
SE 6.671






Male 50.4
CI 26.2 / 74.6
SE 12.347
37.6
CI 21.5 / 53.8
SE 8.249






Age group









45-64 37.3
CI 19.9 / 54.8
SE 8.916
28.3
CI 16.3 / 40.3
SE 6.133






   45-54 45.4
CI 20.2 / 70.7
SE 12.879
30.1
CI 15.9 / 44.3
SE 7.250






   55-64 31.6
CI 17.4 / 45.8
SE 7.242
27.1
CI 15.5 / 38.7
SE 5.918






<18 DSU

DSU







   0-4 DSU

DSU







   12-17 DSU

DSU







   5-11 DSU

DSU







18-44 66.9
CI 33.6 / 100.3
SE 17.003
43.4
CI 23.2 / 63.6
SE 10.328






   18-24 68.8
CI 23.4 / 114.2
SE 23.176
39.0
CI 15.1 / 63.0
SE 12.240






   25-44 66.6
CI 33.5 / 99.8
SE 16.915
44.1
CI 22.4 / 65.8
SE 11.053






65 and over 39.4
CI 20.8 / 58.0
SE 9.501
36.1
CI 19.7 / 52.5
SE 8.386






   85 and over 77.4
CI 25.7 / 129.1
SE 26.374
64.3
CI 22.5 / 106.2
SE 21.352






   75-84 48.4
CI 22.8 / 74.1
SE 13.103
49.4
CI 23.2 / 75.5
SE 13.348






   65-74 27.0
CI 14.8 / 39.3
SE 6.251
24.6
CI 14.2 / 35.1
SE 5.353






Footnotes View Footnotes

1Target has been revised. See Tech Specs for details.

2Baseline has been revised. See Tech Specs for details.

DSU: Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

Data are subject to revision and may have changed since a previous release.

Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.

Data are not available or not collected for populations not shown.

CI: 95% confidence interval.

Emergency department visits for overdoses from narrow-therapeutic-index medications (per 10,000 outpatient prescription visits)

2020 Baseline (year): 8.9 (2006-2007)
2020 Target: 8.01
Desired Direction: Decrease
Populations 2006-20072 2008-2009      
Total 8.9
CI 5.0 / 12.8
SE 2.000
7.6
CI 5.0 / 10.2
SE 1.332






Sex









Male 7.6
CI 4.5 / 10.7
SE 1.601
6.7
CI 4.3 / 9.2
SE 1.259






Female 10.2
CI 5.1 / 15.3
SE 2.588
8.3
CI 5.3 / 11.3
SE 1.521






Age group









65 and over 8.6
CI 3.8 / 13.4
SE 2.452
6.7
CI 3.6 / 9.9
SE 1.618






   65-74 DSU

7.2
CI 3.5 / 10.9
SE 1.893






   75-84 DSU

4.2
CI 2.0 / 6.5
SE 1.159






   85 and over 14.2
CI 6.3 / 22.0
SE 3.989
12.0
CI 4.6 / 19.5
SE 3.813






<18 17.7
CI 9.4 / 26.0
SE 4.252
13.9
CI 6.3 / 21.5
SE 3.892






   0-4 DSU

DSU







   5-11 DSU

DSU







   12-17 DSU

DSU







18-44 8.6
CI 3.4 / 13.9
SE 2.677
7.1
CI 4.5 / 9.7
SE 1.312






   25-44 8.0
CI 3.5 / 12.5
SE 2.311
8.3
CI 5.1 / 11.5
SE 1.611






   18-24 DSU

DSU







45-64 8.3
CI 4.7 / 11.8
SE 1.812
8.4
CI 5.2 / 11.6
SE 1.640






   45-54 10.3
CI 4.7 / 15.8
SE 2.852
8.3
CI 4.7 / 11.9
SE 1.837






   55-64 6.5
CI 3.7 / 9.3
SE 1.421
8.6
CI 4.5 / 12.7
SE 2.095






Footnotes View Footnotes

1Target has been revised. See Tech Specs for details.

2Baseline has been revised. See Tech Specs for details.

DSU: Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

Data are subject to revision and may have changed since a previous release.

Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.

Data are not available or not collected for populations not shown.

CI: 95% confidence interval.

Emergency department visits for medication overdoses in children (per 10,000 population, <5 years)

2020 Baseline (year): 32.7 (2007-2008)
2020 Target: 29.41
Desired Direction: Decrease
Populations 2007-20082 2009-2010      
Total 32.7
CI 25.9 / 39.6
SE 3.488
35.9
CI 27.9 / 43.8
SE 4.051






Sex









Male 34.7
CI 27.6 / 41.9
SE 3.636
36.2
CI 27.5 / 44.8
SE 4.421






Female 30.7
CI 23.6 / 37.7
SE 3.594
35.5
CI 28.1 / 43.0
SE 3.807






Footnotes View Footnotes

1Target has been revised. See Tech Specs for details.

2Baseline has been revised. See Tech Specs for details.

Data are subject to revision and may have changed since a previous release.

Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.

Data are not available or not collected for populations not shown.

CI: 95% confidence interval.